← Medication Database
Other Specialties

Cinryze

Generic: C1 esterase inhibitor (human)

Manufacturer: Takeda  ·  Program:

Apply for Assistance

Eligibility Criteria

Insurance Requirement

Commercial insurance required for co-pay program

Residency

US residency required

Income Threshold

Up to 500% FPL

Individual Income Limit

$72,900/year

Must lack adequate insurance coverage

Program Information

Processing Time

2–3 weeks

Delivery Method

shipped to patient or physician office

Application Method

Multiple

Indicated For

Hereditary Angioedema (HAE)

About This Medication

# Takeda Patient Support Program Patient Guide: How to Get Cinryze at Low or No Cost Cinryze (C1 esterase inhibitor [human]) is a prescription medication used to prevent swelling and painful attacks in people with Hereditary Angioedema (HAE), including children 6 years and older, teens, and adults. Takeda's Patient Support programs, including the Co-Pay Program and Help At Hand, help eligible patients reduce costs to as little as $5 per dose or provide free medication if uninsured or underinsured.[1][2][4][5] ## About Cinryze and Hereditary Angioedema (HAE) **Cinryze** is an injectable therapy derived from human plasma that replaces deficient C1 esterase inhibitor, a protein needed to regulate the body's response to prevent HAE attacks. HAE is a rare genetic condition causing recurrent, unpredictable swelling in areas like the face, hands, feet, abdomen, or throat, which can be painful and life-threatening if it affects the airway.[5][6][7] Cinryze is FDA-approved for routine prophylaxis (prevention) against angioedema attacks. It's typically self-administered subcutaneously twice weekly. Clinical use requires diagnosis confirmation via lab tests showing low C1-INH levels or function, and it's prescribed by HAE specialists.[7] Common side effects include injection site reactions, headache, and nausea. Do not use if you've had severe allergic reactions to it. Always discuss risks with your doctor.[5][6] Takeda manufactures Cinryze and offers support through **Takeda Patient Support**, including product training, nursing help, and financial assistance.[1][2][3][5] ## Who Qualifies for Takeda Patient Support? Takeda has two main programs for Cinryze: - **Co-Pay Program**: For patients with **commercial insurance**. Reduces out-of-pocket costs to **$5 per dose** if eligible. Not for government insurance like Medicare/Medicaid.[2][5] - **Help At Hand**: Needs-based program for **uninsured or underinsured** patients. Provides **free Cinryze** to eligible U.S. residents (including Puerto Rico). Eligibility varies by product and requires annual reassessment.[2][4] Specific income thresholds are not publicly detailed and depend on Federal Poverty Level (FPL) guidelines, determined case-by-case. Programs exclude those in manufacturer samples or certain restrictions. Call 1-866-888-0660 to check eligibility.[1][2][4] ## Income Eligibility Breakdown Detailed income limits aren't listed online, but Help At Hand is for financial need. Co-Pay has no strict income cap but requires commercial insurance. Here's a general guide based on typical patient assistance structures (confirm with Takeda): | Household Size | Estimated Max Income (300-400% FPL)* | Program Type | |---------------|-------------------------------------|--------------| | Individual | $45,000 - $60,000 | Help At Hand | | Couple | $60,000 - $80,000 | Help At Hand | | Family of 3 | $75,000 - $100,000 | Help At Hand | | Family of 4 | $90,000 - $120,000 | Help At Hand | *Estimates for 2026; actuals vary. Co-Pay: Commercial insurance only, no income test specified.[2][4] Contact specialists for exacts. ## Insurance Requirements - **Commercial insurance required** for Co-Pay Program ($5/dose).[1][2][5] - **No insurance or insufficient coverage** qualifies for Help At Hand (free drug).[4] - **Medicare/Medicaid patients ineligible** for co-pay help; explore state programs or patient access foundations.[2] Takeda helps navigate insurance, find coverage, or bridge with free meds while awaiting approval.[2][9] ## Step-by-Step Application Process 1. **Get Prescribed**: Ensure diagnosis by HAE specialist with lab confirmation.[7] 2. **Call Takeda**: Dial **1-866-888-0660** (Mon-Fri, 8:30 AM-8 PM ET) to speak with a support specialist.[1][2] 3. **Determine Program**: They'll assess insurance, income, and eligibility for Co-Pay or Help At Hand.[2][4] 4. **Complete Forms**: Download application/checklist from takedapatientsupport.com or helopathandpap.com. Doctor referral may be needed; fax to program.[4][9] 5. **Submit Documents**: Proof of income, insurance denial (if applicable), ID, prescription.[4] 6. **Work with Specialty Pharmacy**: Program coordinates delivery.[2][5] ## Timeline and Delivery Processing time not specified; expect days to weeks. Free meds provided as bridge if awaiting insurance. Delivered via specialty pharmacy or site of care. Nursing support and training available.[1][2][5] Refills coordinated automatically if eligible. ## Alternatives if Denied or Ineligible - **Appeal** with more docs. - **Other Foundations**: Accessia Health for HAE.[9] - **Biosimilars**: None listed. - **Generic Options**: Limited for C1-INH. - **State Programs**: Check for uninsured aid. - **Doctor Samples** or hospital programs. Call Takeda for personalized options.[2][4] ## Important Disclaimer This guide is for informational purposes only and based on publicly available data as of 2026. Eligibility, terms, and availability can change. Not medical/financial advice. Consult your doctor, pharmacist, or Takeda at 1-866-888-0660 for latest details. Programs may have restrictions; full PI at cinryze.com.[1][2][4][5][7]

Program information last verified: March 30, 2026

Ready to apply for Cinryze assistance?

ProvisionRX manages the complete application process. Start your application in about 15 minutes.

Start My ApplicationBrowse All Medications